Exogenous Antigens Bind MHC Class II First, and Are Processed by Cathepsins Later

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2015 Aug 10

PMID 26254987

Citations 23

Authors

Scheherazade Sadegh-Nasseri

Aeryon Kim

Affiliations

Soon will be listed here.

Abstract

The field of antigen processing and presentation is likely one of the most well defined areas in immunology based on decades of intense molecular and structural studies. Many molecules contributing to antigen processing and presentation have been discovered and their mechanisms of action been largely defined, yet a major question, which lies at the very core of the field has remained hard to pin down. The question is what determines immunodominance? Immunodominance is defined as a few specific epitopes being selected to represent an antigen to the immune system and provide targets for T cells. Many studies have aimed at understanding how epitopes are selected. A range of hypotheses related to the structural features of antigens, sensitivity to proteases, epitope affinity for MHC II, T cell precursor frequency, and T cell receptor affinity for peptide/MHC II have been considered. However, because of the variety of proteins and factors involved in antigen processing and enormous complexity, finding an answer has been challenging. Here we make an effort to tease out the sequence of events in antigen processing that promote selection of immunodominant epitopes for exogenous antigens.

Citing Articles

Antigen presentation of post-translationally modified peptides in major histocompatibility complexes.

de Wit A, Bianchi F, van den Bogaart G Immunol Cell Biol. 2024; 103(2):161-177.

PMID: 39609891 PMC: 11792782. DOI: 10.1111/imcb.12839.

Two MP2CL5 Antigen Vaccines from Naegleria fowleri Stimulate the Immune Response against Meningitis in the BALB/c Model.

Gutierrez-Sanchez M, Carrasco-Yepez M, Correa-Basurto J, Ramirez-Salinas G, Rojas-Hernandez S Infect Immun. 2023; 91(7):e0018123.

PMID: 37272791 PMC: 10353451. DOI: 10.1128/iai.00181-23.

A cell-free antigen processing system informs HIV-1 epitope selection and vaccine design.

Sengupta S, Zhang J, Reed M, Yu J, Kim A, Boronina T J Exp Med. 2023; 220(7).

PMID: 37058141 PMC: 10114365. DOI: 10.1084/jem.20221654.

Molecular Understanding of ACE-2 and HLA-Conferred Differential Susceptibility to COVID-19: Host-Directed Insights Opening New Windows in COVID-19 Therapeutics.

Ul Haq I, Krukiewicz K, Tayyab H, Khan I, Khan M, Yahya G J Clin Med. 2023; 12(7).

PMID: 37048725 PMC: 10095019. DOI: 10.3390/jcm12072645.

Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides Multiple HLA-Types and Confer Anti-Tumor Immunity.

Cook K, Xue W, Atabani S, Symonds P, Al Omari A, Daniels I Front Immunol. 2022; 13:873947.

PMID: 35464453 PMC: 9028767. DOI: 10.3389/fimmu.2022.873947.

References

Rinderknecht C, Roh S, Pashine A, Belmares M, Patil N, Lu N . DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms. Immunology. 2010; 131(1):18-32. PMC: 2966754. DOI: 10.1111/j.1365-2567.2010.03282.x. View

Chou C . HLA-DM recognizes the flexible conformation of major histocompatibility complex class II. J Exp Med. 2000; 192(12):1697-706. PMC: 2213500. DOI: 10.1084/jem.192.12.1697. View

Nguyen H, Steede N, Robinson J, Landry S . Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120. Vaccine. 2015; 33(25):2887-96. PMC: 4443875. DOI: 10.1016/j.vaccine.2015.04.082. View

Nepom G, Lippolis J, White F, Masewicz S, Marto J, Herman A . Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65). Proc Natl Acad Sci U S A. 2001; 98(4):1763-8. PMC: 29331. DOI: 10.1073/pnas.98.4.1763. View

Ma C, Whiteley P, Cameron P, Freed D, Pressey A, Chen S . Role of APC in the selection of immunodominant T cell epitopes. J Immunol. 1999; 163(12):6413-23. View

Sadegh-Nasseri S, Chou C, Hartman I, Kim A, Narayan K . How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci (Schol Ed). 2012; 4(4):1325-32. DOI: 10.2741/s334. View

Natarajan S, Stern L . Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1. J Immunol. 1999; 162(6):3463-70. View

Yin L, Maben Z, Becerra A, Stern L . Evaluating the Role of HLA-DM in MHC Class II-Peptide Association Reactions. J Immunol. 2015; 195(2):706-16. PMC: 4490944. DOI: 10.4049/jimmunol.1403190. View

Dornmair K, Rothenhausler B, McConnell H . Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harb Symp Quant Biol. 1989; 54 Pt 1:409-16. DOI: 10.1101/sqb.1989.054.01.050. View

10.

Natarajan S, Assadi M . Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J Immunol. 1999; 162(7):4030-6. View

11.

Narayan K, Su K, Chou C, Khoruzhenko S, Sadegh-Nasseri S . HLA-DM mediates peptide exchange by interacting transiently and repeatedly with HLA-DR1. Mol Immunol. 2009; 46(15):3157-62. PMC: 2743474. DOI: 10.1016/j.molimm.2009.07.001. View

12.

Jensen P . Antigen unfolding and disulfide reduction in antigen presenting cells. Semin Immunol. 1995; 7(6):347-53. DOI: 10.1006/smim.1995.0039. View

13.

Kim A, Sadegh-Nasseri S . Determinants of immunodominance for CD4 T cells. Curr Opin Immunol. 2015; 34:9-15. PMC: 4444386. DOI: 10.1016/j.coi.2014.12.005. View

14.

Kim A, Hartman I, Poore B, Boronina T, Cole R, Song N . Divergent paths for the selection of immunodominant epitopes from distinct antigenic sources. Nat Commun. 2014; 5:5369. PMC: 4241505. DOI: 10.1038/ncomms6369. View

15.

Hastings K, Cresswell P . Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase. Antioxid Redox Signal. 2011; 15(3):657-68. PMC: 3125571. DOI: 10.1089/ars.2010.3684. View

16.

Poluektov Y, Kim A, Sadegh-Nasseri S . HLA-DO and Its Role in MHC Class II Antigen Presentation. Front Immunol. 2013; 4:260. PMC: 3756479. DOI: 10.3389/fimmu.2013.00260. View

17.

Castellino F, Zappacosta F, Coligan J, Germain R . Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol. 1998; 161(8):4048-57. View

18.

Narayan K, Chou C, Kim A, Hartman I, Dalai S, Khoruzhenko S . HLA-DM targets the hydrogen bond between the histidine at position beta81 and peptide to dissociate HLA-DR-peptide complexes. Nat Immunol. 2006; 8(1):92-100. PMC: 3019572. DOI: 10.1038/ni1414. View

19.

Lindner R, UNANUE E . Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 1996; 15(24):6910-20. PMC: 452517. View

20.

Guillet J, Lai M, Briner T, Smith J, Gefter M . Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature. 1986; 324(6094):260-2. DOI: 10.1038/324260a0. View